Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03741166 · ClinicalTrials.gov registry record
Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.
A clinical trial of Colo-rectal Cancer, sponsored by Exact Sciences Corporation.
- Completed
- Registry status
- 871
- Enrollment target
- 20
- Study locations
NCT03741166 is a study of Colo-rectal Cancer that has completed, run by Exact Sciences Corporation. The registered enrollment target is 871 participants, below the 2,728-participant average among 11 other Colo-rectal Cancer trials with a reported enrollment target (68% lower). The trial reports 20 study locations across 10 states.
The verdict
NCT03741166, a study of Colo-rectal Cancer, has completed, sponsored by Exact Sciences Corporation.
- COMPLETED
- Registry status
- 871 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective of this sub-study, 2018-10B, is to collect blood specimens to assess new biomarkers for the detection of Colorectal Cancer (CRC).
Conditions Studied
Interventions
- OTHER Blood Sample Collection
Study Locations (20)
California
- Ventura County Gastroenterology - Camarillo
- Alliance Research Centers - Laguna Hills
- Focilmed - Oxnard
- Desert Oasis Healthcare Medical Group - Palm Springs
Louisiana
- New Orleans Research Institue - Metairie
- Delta Research Partners, LLC - Monroe
- Louisiana Research Center - Shreveport
Maryland
- Investigative Clinical Research - Annapolis
- Centennial Medical Group - Elkridge
- Capitol Research - Rockville
Connecticut
- Gastroenterology Associates of Fairfield County - Bridgeport
- Yale University Section of Digestive Diseases and Liver Diseases - New Haven
Illinois
- Northshore University Health System Evanston Hospital - Evanston
- DM Clinical Research- Southwest Gastroenterology - Oak Lawn
Indiana
- Deaconess Clinic- Mt. Pleasant - Evansville
- Deaconess Clinic- Gateway - Newburgh
Arizona
- Mayo Clinic Arizona - Phoenix
Florida
- Precision Clinical Research, LLC - Lauderdale Lakes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 871 participants |
| Start Date | 2018-11-08 |
| Est. Completion | 2019-04-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03741166
The ClinicalTrials.gov registry entry for NCT03741166 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 871 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,728-participant average among 11 other Colo-rectal Cancer trials with a reported enrollment target (68% lower). The listed sponsor is Exact Sciences Corporation, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colo-rectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Blood Sample Collection is the first listed.
NCT03741166 reports 20 study locations spanning 10 distinct geographic areas - top geographies include California, Louisiana, Maryland.
Frequently Asked Questions
What is clinical trial NCT03741166 about?
NCT03741166 is a clinical study titled "Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.". The primary objective of this sub-study, 2018-10B, is to collect blood specimens to assess new biomarkers for the detection of Colorectal Cancer (CRC).
What is the current status of trial NCT03741166?
This trial is currently completed. The enrollment target is 871 participants. The study started on 2018-11-08. Estimated completion is 2019-04-05.
What conditions does trial NCT03741166 study?
This clinical trial studies the following conditions: Colo-rectal Cancer.
What interventions are being tested in trial NCT03741166?
The interventions under investigation include: Blood Sample Collection (OTHER).
Who is sponsoring clinical trial NCT03741166?
This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03741166 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colo-rectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
RECRUITING · Phase 3
-
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
RECRUITING · NA
-
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
RECRUITING · Phase 2
-
Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery
RECRUITING · NA
-
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
RECRUITING · Phase 1
-
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.